Vidas D-Dimer Exclusion Ii (DEX2)
Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control. 510(k) K112818, from bioMerieux, Inc. (Hazelwood, MO). Product code DAP, class 2.
As of Nov 21, 2026, K112818 is an FDA 510(k) held by bioMerieux, Inc., substantially equivalent on Jul 31, 2012 after 307 days, with 1 recall tied to it in FDA's recall database.
- Review time: 307 days
- Recalls: 1
- Cited as a predicate by: 1 device
VIDAS® D-Dimer Exclusion II™ is an automated quantitative test for use on the instruments of the VIDAS family for the immunoenzymatic determination of fibrin degradation products (FbDP) in human plasma (sodium citrate, CTAD) using the ELFA technique (Enzyme Linked Fluorescent Assay).
- Vidas D-Dimer Exclusion Assay, Model 30 442K040882 · bioMerieux, Inc. · Jun 10, 2004
- VIDAS H. pylori IgG, VIDAS 3, VIDAS Lyme IgG II, VIDAS RUB IgG, VIDAS TOXO M, VIDAS Human Chorionic Gonadotropin, VIDAS…K141133 · Biomerieux · Jul 9, 2015
| Started | Recall | Status |
|---|---|---|
| Apr 17, 2013 | Z-2232-2014Customer complaints about not repeatable results below the detection limit (<45 ng/mL). Therefore false negatives are being reported for results around the medical decision point of 500 ng/mL that initially tested at… | Terminated |
- INNOVANCE® D-Dimer 2.0 (SMN 10873803)K253985 · Siemens Healthcare Diagnostic Products GmbH · Aug 11, 2026
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Sep 28, 2011
- Review panel
- Hematology
- Regulation
- 21 CFR 864.7320
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files